Program of Symposia
| Thursday, September 10, 2009 | |
| Keynote Lecture |
Clinical Relevance of ET Antagonists: An Update Speaker: Donald E. Kohan |
| Symposia I |
Cellular Regulation of the Endothelin Pathway Chairs: Subrata Chakrabarti and Andrey Sokokin |
| Symposia II |
Pharmacology of Endothelins Chairs: Anthony Davenport and Janet Maguire Speaker: Stephanie W. Watts |
| Symposia III |
Endothelin in Development and Aging Chairs: Eric Thorin and Sandra Davidge Speaker: Christopher A. DeSouza |
| Symposia IV |
Pulmonary Function and Disease Chairs: Bruno J. Battistini and Jocelyn Dupuis |
| Career Symposia |
The Marriage between Academia and the Pharmaceutical Industry –
ET Shows us the Way Chairs: Pedro D’Orléans-Juste and David M. Pollock Panelists: TBD |
| Friday, September 11, 2009 | |
| Symposia VI |
Roles of Endothelin-1 on Cardiac Function and Diseases Chairs: Duncan Stewart and Ghassan Bkaily Speaker: Matthias Barton |
| Symposia VI |
Roles of Endothelin-1 on Vascular Function and Diseases Chairs: Ernesto Schiffrin and Adel Giaid Speaker: Rita Tostes |
| Symposia VI |
Roles of Endothelin-1 Renal, Fluid and Electrolyte Physiology
and Disease Chairs: Ariela Benigni and Donald E. Kohan |
| Ancillary Symposia |
Clinical Trials with ET Antagonists: An Update Chairs: David Pittrow and David Webb Speakers: Joel Nelson, Menno van Burken, and Martine Clozel |
| Saturday, September 12, 2009 | |
| Symposia X |
Roles of Endothelin-1 in Neurophysiology, Stroke and Related
Diseases Chairs: Adviye Ergul and Pierre Moreau Speaker: Edith Hamel |
| Symposia XI |
Endothelin-1 in Cancer and
Blood Diseases Chairs: Raymond L. Benza and Subrata Chakrabarti Speaker: Anna Bagnato |
| Symposia XII |
Endothelin-1 in Inflammatory Diseases and Pain Chairs: Giles Rae and Anil Gulati |
| Highlights |
Highlights of the APS/ET-11
Conference |